FDA Adverse Event Injury Summary report: N

SURGICEL ABSORBABLE HEMOSTAT UNKNOWN

MDR report key: 8113948 · Received November 28, 2018

Report

Report Number
2210968-2018-77390
Event Type
Injury
Date Received
November 28, 2018
Report Date
November 2, 2018
Manufacturer
ETHICON INC.
Product Code
LMF
PMA / PMN Number
N12159
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

PRODUCT COMPLAINT # (B)(4). DATE SENT TO FDA: 11/29/2018. ADDITIONAL INFORMATION: ARTICLE LOCATED: HTTP://DX.DOI.ORG/10.21037/QIMS.2018.09.04. TITLE : HAEMOSTATIC MATERIAL (SURGICEL®) MIMICKING RESIDUAL TUMOUR: MAGNETIC RESONANCE IMAGING FINDINGS IN OPERATED PEDIATRIC NEURO-ONCOLOGY CASES AUTHOR : SERENA STAGLIANÒ, FELICE D¿ARCO, AI PENG TAN, OWASE JEELANI, GIOVANNI MORANA, KSHITIJ MANKAD . CITATION: QUANT IMAGING MED SURG. 2018; 8(9): 971-978. DOI: 10.21037/QIMS.2018.09.04.

Additional Manufacturer Narrative · 1

PRODUCT COMPLAINT #: (B)(4). ADDITIONAL INFORMATION RECEIVED INDICATES THAT THIS EVENT DOES NOT MEET REPORTING SERIOUS INJURY CRITERIA. THIS EVENT THEREFORE IS NOT REPORTABLE. ADDITIONAL INFORMATION WAS REQUESTED AND THE FOLLOWING WAS OBTAINED: DOCTOR / AUTHOR REPORTS: I WOULD LIKE TO HIGHLIGHT THAT THIS PAPER WAS TO HIGHLIGHT A RADIOLOGICAL INTERPRETATION PROBLEM, NOTHING TO DO WITH YOUR PRODUCT AND DOES NOT BELIEVE THERE IS ANY PRODUCT DEFICIENCY.

Additional Manufacturer Narrative · 1

(B)(4). THIS REPORT IS RELATED TO A JOURNAL ARTICLE, THEREFORE NO PRODUCT WILL BE RETURNED FOR ANALYSIS AND THE BATCH HISTORY RECORDS CANNOT BE REVIEWED AS THE LOT NUMBER HAS NOT BEEN PROVIDED. ATTEMPTS ARE BEING MADE TO OBTAIN THE FOLLOWING INFORMATION. TO DATE NO RESPONSE HAS BEEN PROVIDED. IF FURTHER DETAILS ARE RECEIVED AT A LATER DATE A SUPPLEMENTAL MEDWATCH WILL BE SENT. WERE THE CASES DISCUSSED IN THIS ARTICLE PREVIOUSLY REPORTED TO ETHICON? IF YES, PLEASE PROVIDE A COMPLAINT REFERENCE NUMBER. DOES THE SURGEON BELIEVE THAT ETHICON PRODUCTS INVOLVED CAUSED AND/OR CONTRIBUTED TO THE POST-OPERATIVE COMPLICATIONS DESCRIBED IN THE ARTICLE? DOES THE SURGEON BELIEVE THERE WAS ANY DEFICIENCY WITH THE ETHICON PRODUCTS USED IN THIS PROCEDURE? REFERENCE : HAEMOSTATIC MATERIAL (SURGICEL®) MIMICKING RESIDUAL TUMOUR: MAGNETIC RESONANCE IMAGING FINDINGS IN OPERATED PEDIATRIC NEURO-ONCOLOGY CASES AUTHOR : SERENA STAGLIANÒ, FELICE D¿ARCO, AI PENG TAN, OWASE JEELANI, GIOVANNI MORANA, KSHITIJ MANKAD CITATION: QUANT IMAGING MED SURG. 2018; 8(9): 971-978. DOI: 10.21037/QIMS.2018.09.04.

Description of Event or Problem · 1

IT WAS REPORTED IN A JOURNAL ARTICLE ENTITLED: HAEMOSTATIC MATERIAL (SURGICEL®) MIMICKING RESIDUAL TUMOUR: MAGNETIC RESONANCE IMAGING FINDINGS IN OPERATED PEDIATRIC NEURO-ONCOLOGY CASES. THE AIM OF THIS PAPER WAS TO REPORT THREE NEURO-ONCOLOGIC PEDIATRIC CASES WHERE THE PRESENCE OF SURGICEL (ETHICON) IN THE SURGICAL BED CAUSED A DIAGNOSTIC CHALLENGE AND WAS INITIALLY MISDIAGNOSED AS TUMOR RESIDUUM/RECURRENCE. CASE 1, A (B)(6)-YEAR-OLD GIRL WITH A MIXED SOLID-CYSTIC RETRO-CHIASMATIC SUPRASELLAR MASS CENTERED AT THE HYPOTHALAMUS WITH COMPRESSION OF THE OPTIC CHIASM WAS PRESENTED. A DEBULKING SURGERY WAS PERFORMED TO RELIEVE THE COMPRESSION UPON THE OPTIC CHIASM AND OBTAIN TISSUE FOR HISTOPATHOLOGICAL ANALYSIS. SURGICEL (ETHICON) HEMOSTATIC AGENT WAS USED DURING THE PROCEDURE. DURING THE FOLLOW-UP MRI, A DILEMMA BETWEEN MATURING BLOOD CLOT AND RESIDUAL/RECURRENT TUMOR WAS OBSERVED AND A SECOND-LOOK SURGERY WAS PERFORMED. HISTOLOGICAL ANALYSIS SHOWED LACK OF TUMORAL CELLS AND EVIDENCE OF SURGICEL (ETHICON) FOREIGN MATERIAL WITH GRANULOMATOUS REACTION. MRI AFTER THE SURGERY REVEALED NO RESIDUAL ABNORMAL TISSUE. ADDITIONAL INFORMATION HAS BEEN REQUESTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
949218 SURGICEL ABSORBABLE HEMOSTAT UNKNOWN HEMOSTATIC AGENT, ABSORBABLE LMF ETHICON INC.

Patients

Seq Age Sex Outcome Treatment
1 7 YR Required Intervention